BackImmage Biotherapeutics Overview

Immage Biotherapeutics Long Term Debt

Immage Biotherapeutics's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

Immage Biotherapeutics Long Term Debt History

Loading

Immage Biotherapeutics vs. peers: Long Term Debt Comparison

Loading

Immage Biotherapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immage Biotherapeutics (IMMG) FAQ

Immage Biotherapeutics (IMMG) currently reports a long-term debt of $0 as of February 2017. In the prior-year period, the figure was $0. Use the charts on this page to explore Immage Biotherapeutics's long-term debt history and peer comparisons.

Immage Biotherapeutics's long-term debt changed from $0 to $0 (period ending February 2017). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immage Biotherapeutics reported $0 in long-term debt as of February 2017. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immage Biotherapeutics, and consider following IMMG for alerts when major investors trade the stock.